In this webinar, part three of our Transforming Trial Participation webinar series, we will discuss 10 common approaches that actually discourage patient participation in trials.
Watch the replay of part 2 in the Transforming Trial Participation webinar series where we discuss what makes it so hard to increase patient participation in trials from three perspectives.
Ghassan Abou-Alfa, M.D., a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the basics of clinical trials, and why participation in them is important.
Undergoing genetic testing for gastrointestinal (GI) cancers can be both preventative and diagnostic, explained Matthew Yurgelun, M.D., assistant professor of medicine at the Dana-Farber Cancer Institute.
William P. Harris, M.D., associate professor of Medical Oncology at the University of Washington Medical Center and associate member of the Clinical Research Division of the Fred Hutchinson Cancer Center, explains the basics of clinical trials.
We hope you will join us for an interactive, thought-provoking and intriguing 5 part webinar series especially designed for us and our work.
Now that we’re in an era of personalized medicine, patients should not look at statistics and immediately think that they will determine their fate, says Tom Stockwell, patient navigator at the Fibrolamellar Cancer Foundation.
John Hopper, co-chair of the GI Cancer Alliance, president of the Fibrolamellar Cancer Foundation and board member of the National Pancreas Foundation, explains the three steps of undergoing genetic testing.
ACPMP is dedicated to funding research to find a cure for Pseudomyxoma Peritonei (PMP), Appendix Cancer, and related Peritoneal Surface Malignancies (PSM), and funding educational programs to educate physicians and patients about these diseases.
The Community Liver Alliance is dedicated to supporting the community through liver disease awareness, prevention, education and research.
